JNJ vs PRVA · P/E 17, rev $49.37B vs P/E 135, rev $1.24B
Johnson & Johnson (JNJ) versus Privia Health Group Inc (PRVA) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Privia Health Group Inc (PRVA) is a health information services company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported PRVA revenue for 2026-06-30 was $1.24B. Net income was $12.1M. PRVA currently screens at market cap $2.90B and trailing P/E 135.4.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. PRVA currently screens at market cap $2.90B and trailing P/E 135.4.
Not investment advice. Open the JNJ and PRVA stock pages for the full models.
Not investment advice.